XTX Topco’s Enlivex Therapeutics ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-22,659
Closed -$38.1K 2437
2024
Q3
$38.1K Sell
22,659
-2,161
-9% -$3.63K ﹤0.01% 1733
2024
Q2
$35.2K Buy
+24,820
New +$35.2K ﹤0.01% 1544